$19.95
-1.01 (-4.82%)
Performance
1D
—
1W
+5.33%
1M
+4.12%
3M
-20.20%
6M
+1.42%
1Y
+38.45%
YTD
+22.62%
Open$20.93
Previous Close$20.96
Day High$21.09
Day Low$19.89
52W High$27.30
52W Low$13.75
Volume—
Avg Volume1.53M
Market Cap3.03B
P/E Ratio—
EPS$-2.84
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$20.35
Below
SMA 200
$21.26
Below
RSI (14)
71.7
Overbought
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
26 analysts
Price Target
+283.7% upside
Current
$19.95
$19.95
Target
$76.55
$76.55
$56.04
$76.55 avg
$105.76
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 267.02M | 243.47M | 233.58M |
| Net Income | 59.27M | 48.26M | 42.10M |
| Profit Margin | 22.2% | 19.8% | 18.0% |
| EBITDA | 80.54M | 76.00M | 71.04M |
| Free Cash Flow | 42.58M | 43.55M | 31.33M |
| Rev Growth | -5.4% | -1.1% | +3.4% |
| Debt/Equity | 0.51 | 0.57 | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.34 | +1.08% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $461.10 | +0.18% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $168.18 | +0.36% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $546.92 | +0.81% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $908.12 | +0.58% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $157.53 | +0.56% | 28.8 | 23.28B |